Journal Article Summary
The article investigates the effectiveness and safety of combining desloratadine, an antihistamine, with compound glycyrrhizin in treating chronic urticaria (CU), a condition characterized by recurrent hives and itching. This topic is significant because CU affects a notable percentage of the population and can severely impact patients' quality of life. Current treatments often have limited efficacy, and the recurrence of symptoms is common, highlighting the need for improved therapeutic strategies.
The researchers conducted a systematic review and meta-analysis of 14 randomized controlled trials involving a total of 1,501 patients. They found that the combination treatment of desloratadine and compound glycyrrhizin resulted in a higher total response rate and cure rate compared to desloratadine alone. Additionally, patients receiving the combination therapy experienced a lower recurrence rate of symptoms and improved immune function, as indicated by changes in serum IgE levels and T cell counts.
Despite these promising findings, the study has limitations, including variability in patient characteristics and treatment dosages across the included trials, which may affect the results. The quality of the studies was generally low, with many lacking detailed descriptions of randomization and blinding methods. Patients should discuss these findings with their healthcare providers to understand the potential benefits and risks of this combination therapy, especially considering the need for more high-quality research in this area.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Wen Yulong, Tang Yidan, Li Miaoyue, Lai Yu. Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials. Pharmaceutical Biology 2021. DOI: 10.1080/13880209.2021.1973039. PMID: 34517748. PMCID: PMC8451672.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg ā 300 Count Bottle ā Generic For Claritin ā Major / Rugby ā Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
